Soluble LOX-1: A Novel Biomarker in Patients With Coronary Artery Disease, Stroke, and Acute Aortic Dissection?

被引：43
|
作者：
Hofmann, Anja [1 ,2 ]
Brunssen, Coy [1 ]
Wolk, Steffen [2 ]
Reeps, Christian [2 ]
Morawietz, Henning [1 ,3 ]
机构：
[1] Tech Univ Dresden, Med Fac Carl Gustav Carus, Dept Med 3, Div Vasc Endothelium & Microcirculat, Fetscherstr 74, D-01307 Dresden, Germany
[2] Tech Univ Dresden, Med Fac Carl Gustav Carus, Div Vasc & Endovasc Surg, Dept Visceral Thorac & Vasc Surg, Dresden, Germany
[3] Tech Univ Dresden, Univ Hosp Carl Gustav Carus Dresden, Fetscherstr 74, D-01307 Dresden, Germany
来源：
JOURNAL OF THE AMERICAN HEART ASSOCIATION | 2020年 / 9卷 / 01期
关键词：
aortic dissection; coronary artery disease; LOX-1; myocardial infarction; stroke; LOW-DENSITY-LIPOPROTEIN; OXIDIZED LDL RECEPTOR-1; RENIN-ANGIOTENSIN SYSTEM; MYOCARDIAL-INFARCTION; ENDOTHELIAL DYSFUNCTION; OXIDATIVE STRESS; TROPONIN-T; EXPRESSION; MARKER; ATHEROSCLEROSIS;
D O I：
10.1161/JAHA.119.013803
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
[No abstract available]
引用
收藏
页数：13
相关论文
共 50 条
  • [1] Circulatory soluble LOX-1 is a novel predictor for coronary artery disease patients
    Sheikh, Md Sayed Ali
    CARDIOVASCULAR JOURNAL OF AFRICA, 2023, 34 (02) : 104 - 108
  • [2] The LOX-1 scavenger receptor and its implication in coronary artery disease
    Pant, Sadip
    Deshmukh, Abhishek
    Mehta, J. L.
    CLINICAL LIPIDOLOGY, 2012, 7 (03) : 271 - 273
  • [3] LOX-1, a new marker of risk and prognosis in coronary artery disease?
    Lubrano, Valter
    Balzan, Silvana
    MOLECULAR AND CELLULAR BIOCHEMISTRY, 2013, 383 (1-2) : 223 - 230
  • [4] LOX-1, a new marker of risk and prognosis in coronary artery disease?
    Valter Lubrano
    Silvana Balzan
    Molecular and Cellular Biochemistry, 2013, 383 : 223 - 230
  • [5] LOX-1 is a novel marker for peripheral artery disease in patients with type 2 diabetes
    Fukui, Michiaki
    Tanaka, Muhei
    Senmaru, Takafumi
    Nakanishi, Mamoru
    Mukai, Jun
    Ohki, Makoto
    Asano, Mai
    Yamazaki, Masahiro
    Hasegawa, Goji
    Nakamura, Naoto
    METABOLISM-CLINICAL AND EXPERIMENTAL, 2013, 62 (07): : 935 - 938
  • [6] A Novel Serum Biomarker Model to Discriminate Aortic Dissection from Coronary Artery Disease
    Lu, Peijiang
    Feng, Xin
    Li, Rui
    Deng, Peng
    Li, Shiliang
    Xiao, Jiewen
    Fang, Jing
    Wang, Xingyu
    Liu, Chang
    Zhu, Qiuxia
    Wang, Jing
    Fang, Zemin
    Gao, Lu
    Guo, Sen
    Jiang, Xue-Jun
    Zhu, Xue-Hai
    Qin, Tingting
    Wei, Xiang
    Yi, Xin
    Jiang, Ding-Sheng
    DISEASE MARKERS, 2022, 2022
  • [7] Soluble LOX-1: A Potential biomarker for SLE and Cardiovascular Comorbidity
    Sagar, Divya
    Gaddipati, Ranjitha
    Ongstad, Emily
    Rahman, Saifur
    Belkhodja, Mehdi
    Bhagroo, Nicholas
    An, Ling-Ling
    Hasni, Sarfaraz
    Siegal, Richard
    Sanjuan, Miguel A.
    Kolbeck, Roland
    Karathanasis, Sotirios
    Sims, Gary P.
    Gupta, Ruchi
    JOURNAL OF IMMUNOLOGY, 2018, 200 (01):
  • [8] The LOX-1 3'UTR188CT polymorphism and coronary artery disease in Turkish patients
    Kurnaz, Ozlem
    Akadam-Teker, A. Basak
    Yilmaz-Aydogan, Hulya
    Tekeli, Atike
    Isbir, Turgay
    MOLECULAR BIOLOGY REPORTS, 2012, 39 (04) : 4351 - 4358
  • [9] The LOX-1 3′UTR188CT polymorphism and coronary artery disease in Turkish patients
    Özlem Kurnaz
    A. Başak Akadam-Teker
    Hülya Yilmaz-Aydoğan
    Atike Tekeli
    Turgay İsbir
    Molecular Biology Reports, 2012, 39 : 4351 - 4358
  • [10] Serum soluble lectin-like oxidized LDL receptor-1 (soluble LOX-1) as a novel marker for acute coronary syndrome
    Hayashida, K
    Kume, N
    Nakagawa, D
    Inada, T
    Ueda, A
    Kominami, G
    Tanaka, M
    Kita, T
    ATHEROSCLEROSIS SUPPLEMENTS, 2003, 4 (02) : 289 - 289
12345